SCA
CVS icon

Stonebridge Capital Advisors’s CVS Health CVS Stock Holding History

Stonebridge Capital Advisors’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$295K Sell
2,850
-225
-7% -$20.1K 0.02% 182
2026
Q1 		$221K Sell
3,075
-179
-6% -$13.8K 0.02% 194
2025
Q4 		$258K Sell
3,254
-211
-6% -$16.6K 0.02% 185
2025
Q3 		$261K Sell
3,465
-75
-2% -$5.14K 0.02% 185
2025
Q2 		$244K Sell
3,540
-50
-1% -$3.28K 0.02% 192
2025
Q1 		$243K Sell
3,590
-3,738
-51% -$224K 0.02% 185
2024
Q4 		$329K Sell
7,328
-323
-4% -$18.1K 0.03% 161
2024
Q3 		$481K Sell
7,651
-480
-6% -$28K 0.04% 143
2024
Q2 		$480K Sell
8,131
-6,600
-45% -$413K 0.04% 139
2024
Q1 		$1.17M Sell
14,731
-685
-4% -$52.3K 0.11% 116
2023
Q4 		$1.22M Sell
15,416
-91,741
-86% -$6.53M 0.12% 112
2023
Q3 		$7.48M Sell
107,157
-4,153
-4% -$294K 0.82% 42
2023
Q2 		$7.69M Sell
111,310
-3,746
-3% -$267K 0.82% 43
2023
Q1 		$8.55M Sell
115,056
-235
-0.2% -$19.7K 0.98% 38
2022
Q4 		$10.7M Buy
115,291
+386
+0.3% +$37.2K 1.27% 26
2022
Q3 		$11M Sell
114,905
-1,136
-1% -$112K 1.41% 21
2022
Q2 		$10.8M Buy
116,041
+880
+0.8% +$85.9K 1.3% 24
2022
Q1 		$11.7M Sell
115,161
-1,257
-1% -$132K 1.26% 23
2021
Q4 		$12M Buy
116,418
+904
+0.8% +$83.5K 1.33% 20
2021
Q3 		$9.8M Sell
115,514
-114,411
-50% -$9.58M 1.19% 30
2021
Q2 		$18.3M Buy
229,925
+116,007
+102% +$9.5M 1.15% 32
2021
Q1 		$8.57M Buy
113,918
+4,989
+5% +$363K 1.13% 33
2020
Q4 		$7.44M Buy
108,929
+3,487
+3% +$227K 1.13% 34
2020
Q3 		$6.16M Buy
105,442
+5,532
+6% +$344K 1.1% 36
2020
Q2 		$6.49M Buy
99,910
+2,451
+3% +$154K 1.2% 32
2020
Q1 		$5.78M Buy
97,459
+650
+0.7% +$43.4K 1.22% 30
2019
Q4 		$7.19M Buy
96,809
+668
+0.7% +$46.9K 1.17% 31
2019
Q3 		$6.06M Buy
96,141
+94,982
+8,195% +$5.63M 1.05% 36
2019
Q2 		$63K Buy
+1,159
New +$62.4K 0.01% 284

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Stonebridge Capital Advisors's CVS Position: Q2 2026 in Review

Stonebridge Capital Advisors reduced its CVS Health (CVS) stake by 7.3% in Q2 2026, selling an estimated $20.1K and leaving 2,850 shares worth $295K. The position accounts for 0.02% of the portfolio, ranked #182.

Stonebridge Capital Advisors first reported a position in CVS in Q2 2019 and has held it in 29 quarters since. The position peaked at $18.3M in Q2 2021. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Stonebridge Capital Advisors held 2,850 shares of CVS Health worth $295K as of Q2 2026.
  • Stonebridge Capital Advisors sold 225 CVS Health shares in Q2 2026, an estimated $20.1K.
  • CVS Health made up 0.02% of Stonebridge Capital Advisors's portfolio in Q2 2026, its #182 holding.
  • Stonebridge Capital Advisors first reported a position in CVS Health in Q2 2019 and has held it in 29 quarters since.
  • Stonebridge Capital Advisors's CVS Health position peaked at $18.3M in Q2 2021.
  • 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Stonebridge Capital Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.